NASDAQ:CPRX

Catalyst Pharmaceuticals - CPRX Earnings Date, Estimates & Call Transcripts

$16.72

+0.35 (+2.14%)

(As of 03/29/2023 12:00 AM ET)

Add

Compare

Today's Range: $16.45
▼
$16.86
50-Day Range: $14.34
▼
$20.80
52-Week Range: $6.15
▼
$22.11

Volume: 1.36 million shs
Average Volume: 2.34 million shs
Market Capitalization: $1.77 billion

P/E Ratio: 22.59
Dividend Yield: N/A
Price Target: $21.50

Institutional Ownership

Earnings Per Share Revenue

CPRX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CPRX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Catalyst Pharmaceuticals Analyst Forecasts

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2023	2	$0.23	$0.34	$0.29
Q2 2023	2	$0.24	$0.36	$0.30
Q3 2023	2	$0.25	$0.37	$0.31
Q4 2023	2	$0.24	$0.43	$0.34
FY 2023	8	$0.96	$1.50		$1.23

CPRX Earnings Date and Information

Catalyst Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 9th, 2023 based off prior year's report dates.

Catalyst Pharmaceuticals Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
5/9/2023 (Estimated)
11/9/2022	Q3 2022	$0.19	$0.20	+$0.01	$0.20	$53.80 million	$57.24 million
8/9/2022	Q2 2022	$0.17	$0.20	+$0.03	$0.20	$49.29 million	$53.11 million
5/10/2022	Q1 2022	$0.14	$0.12	($0.02)	$0.12	$43.17 million	$43.09 million
3/16/2022	Q4 2021	$0.12	$0.09	($0.03)	$0.09	$38.17 million	$38.31 million
11/9/2021	9/30/2021	$0.10	$0.10		$0.10	$34.47 million	$35.95 million
8/8/2021	6/30/2021	$0.10	$0.11	+$0.01	$0.17	$31.25 million	$36.37 million

5/9/2021	3/31/2021	$0.09	$0.07	($0.02)	$0.11	$32.14 million	$30.21 million
3/16/2021	12/31/2020	$0.09	$0.11	+$0.02	$0.11	$30.06 million	$31.02 million
11/16/2020	9/30/2020	$0.10	$0.11	+$0.01	($0.19)	$31.22 million	$29.32 million
8/10/2020	6/30/2020	$0.08	$0.09	+$0.01	$0.09	$28.97 million	$29.61 million
5/11/2020	3/31/2020	$0.09	$0.10	+$0.01	$0.10	$31.68 million	$29.14 million
3/16/2020	12/31/2019	$0.10	$0.08	($0.02)	$0.07	$30.00 million	$30.12 million
11/12/2019	Q3 2019	$0.11	$0.13	+$0.02	$0.13	$33.19 million	$30.90 million
8/7/2019	Q2 2019	$0.03	$0.10	+$0.07	$0.10	$17.99 million	$28.84 million
5/13/2019	3/31/2019	($0.13)	($0.01)	+$0.12	($0.01)	$2.40 million	$12.45 million
3/18/2019	12/31/2018	($0.12)	($0.14)	($0.02)	($0.14)		$0.50 million
11/8/2018	9/30/2018	($0.08)	($0.08)		($0.08)
8/10/2018	Q2 2018	($0.08)	($0.0580)	+$0.0220	($0.06)
5/9/2018	Q1 2018	($0.06)	($0.06)		($0.06)
3/14/2018	Q4 2017	($0.06)	($0.06)		($0.06)
11/8/2017	Q3 2017	($0.06)	($0.05)	+$0.01	($0.05)
8/9/2017	Q2 2017	($0.06)	($0.0460)	+$0.0140	($0.05)
5/10/2017	Q1 2017	($0.06)	($0.06)		($0.06)
3/15/2017	Q4 2016	($0.07)	($0.05)	+$0.02	($0.05)
11/9/2016	Q316	($0.06)	($0.05)	+$0.01	($0.05)
8/9/2016	Q216	($0.08)	($0.06)	+$0.02	($0.06)
5/10/2016	Q116	($0.07)	($0.07)		($0.07)
3/15/2016	Q415	($0.07)	($0.07)		($0.07)
11/9/2015	Q3 2015	($0.07)	($0.06)	+$0.01	($0.07)
8/10/2015	Q215	($0.08)	($0.06)	+$0.02	($0.06)
5/11/2015	Q115	($0.08)	($0.06)	+$0.02	($0.05)
3/16/2015	Q414	($0.07)	($0.06)	+$0.01	($0.07)
11/14/2014	Q314	($0.06)	($0.06)		($0.05)
8/14/2014	Q214	($0.08)	($0.05)	+$0.03	($0.05)
5/16/2014	Q1 2014	($0.08)	($0.06)	+$0.02	($0.05)
3/19/2014	Q4 2013	($0.07)	($0.05)	+$0.02	($0.07)
11/14/2013	Q3 2013	($0.07)	($0.07)		($0.01)
8/15/2013	Q2 2013	($0.07)	($0.06)	+$0.01	($0.04)
5/16/2013	Q1 2013	($0.07)	($0.04)	+$0.03	($0.04)
4/2/2013	Q4 2012		($0.05)	($0.05)	($0.10)

11/15/2012	Q312		($0.08)	($0.08)
8/15/2012	Q2 2012	($0.04)	($0.01)	+$0.03	($0.01)
5/16/2012	Q1 2012	($0.08)	($0.04)	+$0.04	($0.04)
4/2/2012	Q4 2011	($0.06)	($0.09)	($0.03)	($0.08)
11/15/2011	Q3 2011	($0.07)	($0.05)	+$0.02	($0.05)
8/16/2011	Q2 2011	($0.08)	($0.06)	+$0.02	($0.06)
5/16/2011	Q1 2011		($0.08)	($0.08)	($0.08)
4/1/2011	Q4 2010	($0.07)	($0.04)	+$0.03	($0.04)
11/16/2010	Q3 2010	($0.09)	($0.05)	+$0.04	($0.05)
8/13/2010	Q2 2010	($0.07)	($0.07)		($0.07)
5/18/2010	Q1 2010		($0.06)	($0.06)	($0.06)
4/1/2010	Q4 2009		($0.06)	($0.06)	($0.06)
11/12/2009	Q3 2009	($0.11)	($0.09)	+$0.02	($0.09)
8/7/2009	Q2 2009	($0.20)	($0.13)	+$0.07	($0.13)
5/14/2009	Q1 2009	($0.29)	($0.22)	+$0.07	($0.22)
3/27/2009	Q4 2008	($0.27)	($0.27)		($0.27)
11/14/2008	Q3 2008		($0.22)	($0.22)	($0.22)
8/15/2008	Q2 2008	($0.14)	($0.19)	($0.05)	($0.19)
5/16/2008	Q1 2008	($0.12)	($0.13)	($0.01)	($0.13)
3/26/2008	Q4 2007	($0.07)	($0.07)		($0.07)

Catalyst Pharmaceuticals Earnings - Frequently Asked Questions

When is Catalyst Pharmaceuticals's earnings date?: Catalyst Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 9th, 2023 based off last year's report dates. Learn more on CPRX's earnings history.

How much revenue does Catalyst Pharmaceuticals generate each year?: Catalyst Pharmaceuticals (NASDAQ:CPRX) has a recorded annual revenue of $214.20 million.
How much profit does Catalyst Pharmaceuticals generate each year?: Catalyst Pharmaceuticals (NASDAQ:CPRX) has a recorded net income of $83.08 million. CPRX has generated $0.74 earnings per share over the last four quarters.
What is Catalyst Pharmaceuticals's price-to-earnings ratio?: Catalyst Pharmaceuticals (NASDAQ:CPRX) has a trailing price-to-earnings ratio of 22.59 and a forward price-to-earnings ratio of 11.86.
What is Catalyst Pharmaceuticals's EPS forecast for next year?: Catalyst Pharmaceuticals's earnings are expected to grow from $1.41 per share to $1.58 per share in the next year, which is a 12.06% increase.

More Earnings Resources from MarketBeat

Earnings Tools:

Earnings By Country:

Latest Articles:

Upcoming Earnings:

BlackRock (4/12/2023)
Infosys (4/12/2023)
Progressive (4/13/2023)
Taiwan Semiconductor Manufacturing (4/13/2023)
U.S. Bancorp (4/13/2023)
Wells Fargo & Company (4/13/2023)
Citigroup (4/14/2023)
JPMorgan Chase & Co. (4/14/2023)
The PNC Financial Services Group (4/14/2023)
UnitedHealth Group (4/14/2023)

This page (NASDAQ:CPRX) was last updated on 3/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Catalyst Pharmaceuticals - CPRX Earnings Date, Estimates & Call Transcripts

CPRX Earnings Estimates and Actuals by Quarter

CPRX Estimated and Actual Revenue by Quarter

Catalyst Pharmaceuticals Analyst Forecasts

CPRX Earnings Date and Information

Catalyst Pharmaceuticals Earnings History by Quarter

Catalyst Pharmaceuticals Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info